Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility

Oncogene

Volumn 33, Issue 2, 2014, Pages 193-202

  Yang, Q ^a   Jie, Z ^b   Ye, S ^c   Li, Z ^b   Han, Z ^a   Wu, J ^a   Yang, C ^d   Jiang, Y ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

gastric tumorigenesis; microRNA; miR 27a; single nucleotide polymorphisms

Indexed keywords

METHYLNITRONITROSOGUANIDINE; MICRORNA; MICRORNA 27A; TRANSCRIPTION FACTOR HOXA10; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CELL INVASION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HOX GENE; HUMAN; IN VITRO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH CANCER; STOMACH CARCINOGENESIS;

3' UNTRANSLATED REGIONS; ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 84891933548     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.569     Document Type: Article

References (44)

1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9
2. Bornschein J, Rokkas T, Selgrad M, Malfertheiner P. Gastric cancer: Clinical aspects, epidemiology and molecular background. Helicobacter 2011; 16(Suppl 1): 45-52
3. Gonzá lez CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go. Int J Cancer 2012; 130: 745-753
4. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14: 243-250
5. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL et al. Screening for gastric cancer in Asia: Current evidence and practice. Lancet Oncol 2008; 9: 279-287
6. Esquela-Kerscher A, Slack FJ. Oncomirs -microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269
7. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655
8. Iorio MV, Croce CM. MicroRNAs in cancer: Small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856
9. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419
10. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18: 3016-3027
11. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901
12. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205
13. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71
14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999-3004
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838
16. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866
17. Calin GA, Croce CM. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006; 66: 7390-7394
18. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X et al. MicroRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009; 15: 2281-2290
19. Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 2011; 17: 4277-4284
20. Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, Zou F et al. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis 2011; 32: 713-722
21. Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G et al. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 2009; 125: 1965-1974
22. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009; 273: 233-242
23. Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Moqadam FA et al. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 2011; 10: 2172-2183
24. Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B et al. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 2011; 30: 3875-3886
25. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y et al. microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 2009; 34: 537-542
26. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-677
27. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007; 104: 3300-3305
28. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009; 15: 1640-1651
29. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: The implications for cancer research. Nat Rev Cancer 2010; 10: 389-402
30. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798
31. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y et al. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 2010; 101: 2241-2247
32. Zhou Y, Du WD, Chen G, Ruan J, Xu S, Zhou FS et al. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol 2012; 138: 939-945
33. Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall'olio V, Sardella D et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. J Cancer Res Clin Oncol 2012; 133: 805-807
34. Zhang M, Jin M, Yu Y, Zhang S, Wu Y, Liu H et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care 2012; 21: 274-280
35. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16: 1124-1131
36. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-7274
37. Hu Y, Liu CM, Qi L, He TZ, Shi-Guo L, Hao CJ et al. Two common SNPs in pri-miR-125a alter the mature miRNA expression and associate with recurrent pregnancy loss in a Han-Chinese population. RNA Biol 2011; 8: 258-264
38. Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008; 10: 788-801
39. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B et al. A Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 2009; 106: 1502-1505
40. Nunes FD, de Almeida FC, Tucci R, de Sousa SC. Homeobox genes: A molecular link between development and cancer. Pesqui Odontol Bras 2003; 17: 94-98
41. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361-371
42. Plowright L, Harrington KJ, Pandha HS, Morgan R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009; 100: 470-475
43. Cantile M, Franco R, Schiavo G, Procino A, Cindolo L, Botti G et al. The HOX genes network in uro-genital cancers: Mechanisms and potential therapeutic implications. Curr Med Chem 2011; 18: 4872-4884
44. Cillo C, Schiavo G, Cantile M, Bihl MP, Sorrentino P, Carafa V et al. The HOX gene network in hepatocellular carcinoma. Int J Cancer 2011; 29: 2577-2587